VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of $1.20 million. The enterprise value is -$3.25 million.
| Market Cap | 1.20M |
| Enterprise Value | -3.25M |
Important Dates
The next estimated earnings date is Friday, August 7, 2026, after market close.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VivoSim Labs has 3.49 million shares outstanding. The number of shares has increased by 76.85% in one year.
| Current Share Class | 3.49M |
| Shares Outstanding | 3.49M |
| Shares Change (YoY) | +76.85% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 8.97% |
| Owned by Institutions (%) | 2.81% |
| Float | 3.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.19 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.38
| Current Ratio | 2.38 |
| Quick Ratio | 2.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -957.25 |
Financial Efficiency
Return on equity (ROE) is -294.75% and return on invested capital (ROIC) is -130.20%.
| Return on Equity (ROE) | -294.75% |
| Return on Assets (ROA) | -65.16% |
| Return on Invested Capital (ROIC) | -130.20% |
| Return on Capital Employed (ROCE) | -249.66% |
| Weighted Average Cost of Capital (WACC) | 8.67% |
| Revenue Per Employee | $8,733 |
| Profits Per Employee | -$922,867 |
| Employee Count | 15 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VivoSim Labs has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.86% in the last 52 weeks. The beta is 1.40, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -82.86% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 1.70 |
| Relative Strength Index (RSI) | 20.67 |
| Average Volume (20 Days) | 11,001,505 |
Short Selling Information
The latest short interest is 48,730, so 1.39% of the outstanding shares have been sold short.
| Short Interest | 48,730 |
| Short Previous Month | 113,911 |
| Short % of Shares Out | 1.39% |
| Short % of Float | 1.53% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, VivoSim Labs had revenue of $131,000 and -$13.84 million in losses. Loss per share was -$5.35.
| Revenue | 131,000 |
| Gross Profit | -4.06M |
| Operating Income | -11.49M |
| Pretax Income | -13.84M |
| Net Income | -13.84M |
| EBITDA | -11.27M |
| EBIT | -11.49M |
| Loss Per Share | -$5.35 |
Balance Sheet
The company has $5.02 million in cash and $565,000 in debt, with a net cash position of $4.46 million or $1.28 per share.
| Cash & Cash Equivalents | 5.02M |
| Total Debt | 565,000 |
| Net Cash | 4.46M |
| Net Cash Per Share | $1.28 |
| Equity (Book Value) | -1.10M |
| Book Value Per Share | -0.38 |
| Working Capital | 3.84M |
Cash Flow
| Operating Cash Flow | -10.83M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 215,000 |
| Net Borrowing | -363,000 |
| Free Cash Flow | -10.83M |
| FCF Per Share | -$3.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | -8,768.70% |
| Pretax Margin | -10,565.65% |
| Profit Margin | n/a |
| EBITDA Margin | -8,604.58% |
| EBIT Margin | -8,768.70% |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.85% |
| Shareholder Yield | -76.85% |
| Earnings Yield | -1,149.70% |
| FCF Yield | -899.21% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
VivoSim Labs has an Altman Z-Score of -71.6 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -71.6 |
| Piotroski F-Score | 2 |